THE ARTICLES ON THESE PAGES ARE PRODUCED BY BUSINESS REPORTER, WHICH TAKES SOLE RESPONSIBILITY FOR THE CONTENTS ...
FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.
Elite Pharmaceuticals, Inc. ( OTCQB:ELTP) Q2 2026 Earnings Call November 17, 2025 11:30 AM EST Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Second Quarter of Fiscal ...
Q3 2025 Earnings Call November 17, 2025 8:30 AM ESTCompany ParticipantsMatthew Duffy - Chief Business Officer & ...
The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
Detailed price information for Medexus Pharmaceuticals Inc (MDP-T) from The Globe and Mail including charting and trades.
Cannabis retailers and product manufacturers are moving away from potency and embracing products that offer "functional THC." ...
There are now over 200 carriers offering cyber insurance products in the US alone. That heightened competition has accelerated innovation and helped bring more client-centric solutions to market—but ...
An advocate for women’s reproductive health, she started one of the world’s smallest pharmaceutical companies to bring an ...
Jack Kelliher of Racing and Sports explains just how to maximise a horse racing product, and why punters will keep coming ...
NRx has refiled its Abbreviated New Drug Application for KETAFREE™ (preservative free ketamine), received supportive correspondence from FDA, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback